COO and Co-founder
Ruchi Chauhan did her Ph.D. working at the Harvard University. Thereafter, she worked as a scientist at Merck Pharmaceuticals, Compass Therapeutics, and at the University of Cambridge. She has 20 years of research experience working in proteogenomics, molecular target validation, drug discovery, cancer, and neurodegenerative disorders. She was the head of the Gene Therapy vector development core at the Harvard University until 2021. In addition to research, she gained technology commercialization experience as a business development fellow at the Harvard’s technology transfer office. She also developed and managed Pharma-University alliances for Cambridge Academy of Therapeutic Sciences at the University of Cambridge. She works with NonExomics R&D team and develops business alliances for NonExomics in USA, India, and the UK.